BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massie AB, Chow EK, Wickliffe CE, Luo X, Gentry SE, Mulligan DC, Segev DL. Early changes in liver distribution following implementation of Share 35. Am J Transplant 2015;15:659-67. [PMID: 25693474 DOI: 10.1111/ajt.13099] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
Number Citing Articles
1 Adler JT, Yeh H, Markmann JF, Axelrod DA. Is Donor Service Area Market Competition Associated With Organ Procurement Organization Performance? Transplantation 2016;100:1349-55. [DOI: 10.1097/tp.0000000000000979] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
2 Parikh ND, Marrero WJ, Sonnenday CJ, Lok AS, Hutton DW, Lavieri MS. Population-Based Analysis and Projections of Liver Supply Under Redistricting. Transplantation 2017;101:2048-55. [DOI: 10.1097/tp.0000000000001785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
3 Cholankeril G, Perumpail RB, Tulu Z, Jayasekera CR, Harrison SA, Hu M, Esquivel CO, Ahmed A. Trends in Liver Transplantation Multiple Listing Practices Associated With Disparities in Donor Availability: An Endless Pursuit to Implement the Final Rule. Gastroenterology 2016;151:382-386.e2. [DOI: 10.1053/j.gastro.2016.07.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Singal AK, Ong S, Satapathy SK, Kamath PS, Wiesner RH. Simultaneous liver kidney transplantation. Transpl Int 2019;32:343-52. [DOI: 10.1111/tri.13388] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
5 Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet. 2015;386:1576-1587. [PMID: 26423181 DOI: 10.1016/s0140-6736(15)00309-8] [Cited by in Crossref: 153] [Cited by in F6Publishing: 59] [Article Influence: 21.9] [Reference Citation Analysis]
6 Pedersen MR, Choi M, Brink JA, Seetharam AB. Pretransplant Factors and Associations with Postoperative Respiratory Failure, ICU Length of Stay, and Short-Term Survival after Liver Transplantation in a High MELD Population. J Transplant 2016;2016:6787854. [PMID: 27980860 DOI: 10.1155/2016/6787854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
7 Ghabril M, Charlton M. Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice. Gastroenterology 2015;149:531-4. [PMID: 26226568 DOI: 10.1053/j.gastro.2015.07.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Perumpail RB, Hahambis TA, Aggarwal A, Younossi ZM, Ahmed A. Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World J Hepatol 2016; 8(1): 69-73 [PMID: 26783422 DOI: 10.4254/wjh.v8.i1.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
9 Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017;37:317-327. [PMID: 27634369 DOI: 10.1111/liv.13255] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
10 Anwar N, Kaiser TE, Bari K, Schoech M, Diwan TS, Cuffy MC, Silski L, Quillin RC, Safdar K, Shah SA. Use of Hepatitis C Nucleic Acid Test–Positive Liver Allografts in Hepatitis C Virus Seronegative Recipients. Liver Transpl 2020;26:673-80. [DOI: 10.1002/lt.25741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Feng S, O’Grady J. Share 35: a liver in time saves lives? Am J Transplant. 2015;15:581-582. [PMID: 25693468 DOI: 10.1111/ajt.13102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
12 Chow EK, Massie AB, Luo X, Wickliffe CE, Gentry SE, Cameron AM, Segev DL. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35. Am J Transplant 2017;17:512-8. [PMID: 27457221 DOI: 10.1111/ajt.13980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Bowring MG, Zhou S, Chow EKH, Massie AB, Segev DL, Gentry SE. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35. Transplantation 2019;103:2113-20. [PMID: 30801545 DOI: 10.1097/TP.0000000000002643] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
14 Leventhal TM, Florek E, Chinnakotla S. Changes in liver allocation in United States. Current Opinion in Organ Transplantation 2020;25:52-8. [DOI: 10.1097/mot.0000000000000726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
15 Gilroy R, Bucuvalas J. Share 35 has us too wary of strangers bearing gifts. Liver Transpl 2016;22:159-60. [PMID: 26663509 DOI: 10.1002/lt.24381] [Reference Citation Analysis]
16 Gentry SE, Chow EK, Dzebisashvili N, Schnitzler MA, Lentine KL, Wickliffe CE, Shteyn E, Pyke J, Israni A, Kasiske B, Segev DL, Axelrod DA. The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients. Am J Transplant 2016;16:583-93. [PMID: 26779694 DOI: 10.1111/ajt.13569] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
17 Hartsock JA, Ivy SS, Helft PR. Liver Allocation to Non-U.S. Citizen Non-U.S. Residents: An Ethical Framework for a Last-in-Line Approach. Am J Transplant 2016;16:1681-7. [DOI: 10.1111/ajt.13674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Edwards EB, Harper AM, Hirose R, Mulligan DC. The impact of broader regional sharing of livers: 2-year results of "Share 35". Liver Transpl 2016;22:399-409. [PMID: 26890858 DOI: 10.1002/lt.24418] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
19 Zhang Y. The Impact of the Share 35 Policy on Racial and Ethnic Disparities in Access to Liver Transplantation for Patients with End Stage Liver Disease in the United States: An Analysis from UNOS Database. Int J Equity Health 2017;16:55. [PMID: 28340592 DOI: 10.1186/s12939-017-0552-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
20 Massie AB, Luo X, Lonze BE, Desai NM, Bingaman AW, Cooper M, Segev DL. Early Changes in Kidney Distribution under the New Allocation System. J Am Soc Nephrol 2016;27:2495-501. [PMID: 26677865 DOI: 10.1681/ASN.2015080934] [Cited by in Crossref: 58] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
21 Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A. Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation. Dig Dis Sci 2017;62:801-7. [PMID: 28054162 DOI: 10.1007/s10620-016-4423-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Kalra A, Biggins SW. New paradigms for organ allocation and distribution in liver transplantation. Current Opinion in Gastroenterology 2018;34:123-31. [DOI: 10.1097/mog.0000000000000434] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
23 Wey A, Noreen S, Gentry S, Cafarella M, Trotter J, Salkowski N, Segev D, Israni A, Kasiske B, Hirose R, Snyder J. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses. Liver Transpl 2021. [PMID: 34482614 DOI: 10.1002/lt.26286] [Reference Citation Analysis]
24 Zhang Y, Boktour MR. The Impact of Share 35 Policy on Patient Survival in Patients Undergoing Liver Transplantation With Gender- and Race-Mismatched Donors: An Analysis of the United Network for Organ Sharing Registry. Prog Transplant 2018;28:151-6. [PMID: 29558873 DOI: 10.1177/1526924818765802] [Reference Citation Analysis]
25 Fleming JN, Taber DJ, Axelrod D, Chavin KD. The effect of Share 35 on biliary complications: An interrupted time series analysis. Am J Transplant 2019;19:221-6. [PMID: 29767478 DOI: 10.1111/ajt.14937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Stine JG, Northup PG, Stukenborg GJ, Cornella SL, Maluf DG, Pelletier SJ, Argo CK. Geographic variation in liver transplantation persists despite implementation of Share35: Regional disparities persist in liver transplantation. Hepatol Res 2018;48:225-32. [DOI: 10.1111/hepr.12922] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
27 Shang J, Wang M, Wen Q, Ma Y, Chen F, Xu Y, Liu CH, Bai L, Tang H. A novel prognostic model to predict outcome of artificial liver support system treatment. Sci Rep 2021;11:7510. [PMID: 33820919 DOI: 10.1038/s41598-021-87055-8] [Reference Citation Analysis]
28 Hart A, Schladt DP, Zeglin J, Pyke J, Kim WR, Lake JR, Roberts JP, Hirose R, Mulligan DC, Kasiske BL, Snyder JJ, Israni AK. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation 2016;100:2153-9. [PMID: 27490411 DOI: 10.1097/TP.0000000000001384] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
29 Taner T, Heimbach JK. We (Now) Know What We Are, But Not What We May Be. Transplantation 2019;103:1978-9. [PMID: 31568230 DOI: 10.1097/TP.0000000000002644] [Reference Citation Analysis]
30 Wey A, Pyke J, Schladt DP, Gentry SE, Weaver T, Salkowski N, Kasiske BL, Israni AK, Snyder JJ. Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant. Liver Transpl 2018;24:478-87. [PMID: 29316203 DOI: 10.1002/lt.25010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
31 Formica RN. Simultaneous liver kidney transplantation: . Current Opinion in Nephrology and Hypertension 2016;25:577-82. [DOI: 10.1097/mnh.0000000000000260] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
32 Malik AK, Masson S, Allen E, Akyol M, Bathgate A, Davies M, Hidalgo E, Hudson M, Powell J, Taylor R, Zarankaite A, Manas DM; UK Northern Liver Alliance. Impact of Regional Organ Sharing and Allocation in the UK Northern Liver Alliance on Waiting Time to Liver Transplantation and Waitlist Survival. Transplantation 2019;103:2304-11. [PMID: 30830042 DOI: 10.1097/TP.0000000000002687] [Reference Citation Analysis]
33 Pillai A, Couri T, Charlton M. Liver Allocation Policies in the USA: Past, Present, and the Future. Dig Dis Sci 2019;64:985-92. [DOI: 10.1007/s10620-019-05549-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
34 Halazun KJ, Mathur AK, Rana AA, Massie AB, Mohan S, Patzer RE, Wedd JP, Samstein B, Subramanian RM, Campos BD, Knechtle SJ. One Size Does Not Fit All—Regional Variation in the Impact of the Share 35 Liver Allocation Policy. American Journal of Transplantation 2015;16:137-42. [DOI: 10.1111/ajt.13500] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
35 Samstein B, McElroy LM. Agree on much, except it is time for change. Am J Transplant 2019;19:1912-6. [PMID: 30884119 DOI: 10.1111/ajt.15362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Croome KP, Lee DD, Harnois D, Taner CB. Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma. PLoS One 2017;12:e0170673. [PMID: 28122003 DOI: 10.1371/journal.pone.0170673] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
37 Nekrasov V, Matsuoka L, Rauf M, Kaur N, Cao S, Groshen S, Alexopoulos SP. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35. Am J Transplant 2016;16:2912-24. [DOI: 10.1111/ajt.13823] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
38 Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Dig Dis Sci 2018;63:1647-53. [DOI: 10.1007/s10620-018-5032-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
39 Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou LQ, Yeh BM, Lai JC. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study. Transplantation. 2016;100:1692-1698. [PMID: 27314169 DOI: 10.1097/TP.0000000000001232] [Cited by in Crossref: 67] [Cited by in F6Publishing: 24] [Article Influence: 13.4] [Reference Citation Analysis]
40 Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: Current limitations and future directions. World J Hepatol 2021; 13(8): 830-839 [PMID: 34552690 DOI: 10.4254/wjh.v13.i8.830] [Reference Citation Analysis]
41 Lee J, Kim DG, Lee JY, Lee JG, Joo DJ, Kim SI, Kim MS. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study. Transplantation. 2019;103:2515-2522. [PMID: 30985735 DOI: 10.1097/tp.0000000000002755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Hirose R. Liver Allograft Allocation and Distribution: Toward a More Equitable System. Curr Transpl Rep 2016;3:64-74. [DOI: 10.1007/s40472-016-0096-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Zhang X, Ying Y, Zhou P, Liu X, Li R, Tao Y, Dong M, Zhu B, Qi X, Wang Q, Zhang X, Wu J, Zheng J, Zhao W, Zhang W, Wang Z, Zhang J, Huang Y. A Stepwise Evaluation of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure to Optimize the Indication for Urgent Liver Transplantation. Dig Dis Sci 2021;66:284-95. [PMID: 32140946 DOI: 10.1007/s10620-020-06149-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Dagher NN. Living Donor Liver Transplantation: A Western Perspective. Int Anesthesiol Clin 2017;55:135-47. [PMID: 28288032 DOI: 10.1097/AIA.0000000000000135] [Reference Citation Analysis]
45 Goldberg DA, Gilroy R, Charlton M. New organ allocation policy in liver transplantation in the United States. Clin Liver Dis (Hoboken) 2016;8:108-12. [PMID: 31041075 DOI: 10.1002/cld.580] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
46 Heimbach JK. The benefit of sharing. Hepatology 2018;67:16-7. [PMID: 28806474 DOI: 10.1002/hep.29467] [Reference Citation Analysis]
47 Ioannou GN. How can we improve prioritization for liver transplantation in patients with hepatocellular carcinoma? Liver Transpl 2016;22:1321-3. [PMID: 27541631 DOI: 10.1002/lt.24604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
48 Bittermann T, Goldberg DS. Financial impact of share 35: Encouraging early results but many unanswered questions. Liver Transpl 2017;23:9-10. [PMID: 27809404 DOI: 10.1002/lt.24673] [Reference Citation Analysis]
49 Tsuang WM. Contemporary Issues in Lung Transplant Allocation Practices. Curr Transplant Rep 2017;4:238-42. [PMID: 28948134 DOI: 10.1007/s40472-017-0160-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Zhang Q, Wang M. Value of Model for End-Stage Liver Disease-Serum Sodium Scores in Predicting Complication Severity Grades After Liver Transplantation for Acute-on-chronic Liver Failure. Transplantation Proceedings 2019;51:833-41. [DOI: 10.1016/j.transproceed.2019.01.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Brooks JT, Koizumi N, Neglia E, Gdoura B, Wong TW, Kwon C, Smith TE, Ortiz J. Improved retransplant outcomes: early evidence of the share35 impact. HPB 2018;20:649-57. [DOI: 10.1016/j.hpb.2018.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Kwong AJ, Goel A, Mannalithara A, Kim WR. Improved posttransplant mortality after share 35 for liver transplantation. Hepatology. 2018;67:273-281. [PMID: 28586179 DOI: 10.1002/hep.29301] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
53 Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. J Hepatol 2017;67:517-25. [PMID: 28483678 DOI: 10.1016/j.jhep.2017.04.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
54 Cholankeril G, Yoo ER, Perumpail RB, Younossi ZM, Ahmed A. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices. Clinical Gastroenterology and Hepatology 2017;15:313-5. [DOI: 10.1016/j.cgh.2016.08.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
55 Chow EK, DiBrito S, Luo X, Wickliffe CE, Massie AB, Locke JE, Gentry SE, Garonzik-Wang J, Segev DL. Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation 2018;102:471-7. [PMID: 28938312 DOI: 10.1097/TP.0000000000001957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
56 Nicolas CT, Nyberg SL, Heimbach JK, Watt K, Chen HS, Hathcock MA, Kremers WK. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality. Liver Transpl 2017;23:11-8. [PMID: 27658200 DOI: 10.1002/lt.24641] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
57 Ha SM, Hwang S, Song GW, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Kim KH, Kim DY, Namgung J, Kang WH, Kim SH, Jwa E, Kwon JH, Cho HD, Jung YK, Kang SH, Lee SG. Successful introduction of Model for End-stage Liver Disease scoring in deceased donor liver transplantation in Korea: analysis of first 1 year experience at a high-volume transplantation center. Ann Hepatobiliary Pancreat Surg 2017;21:199-204. [PMID: 29264582 DOI: 10.14701/ahbps.2017.21.4.199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
58 Gentry SE, Segev DL, Kasiske BL, Mulligan DC, Hirose R. Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity. Transplantation 2015;99:e159-60. [PMID: 26308421 DOI: 10.1097/TP.0000000000000834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
59 Lapisatepun W, Agopian VG, Xia VW, Lapisatepun W. Impact of the Share 35 Policy on Perioperative Management and Mortality in Liver Transplantation Recipients. Ann Transplant 2021;26:e932895. [PMID: 34711796 DOI: 10.12659/AOT.932895] [Reference Citation Analysis]
60 Nagai S, Chau LC, Schilke RE, Safwan M, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Moonka D. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes. Gastroenterology 2018;155:1451-1462.e3. [DOI: 10.1053/j.gastro.2018.07.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
61 Washburn K, Harper A, Baker T, Edwards E. Changes in liver acceptance patterns after implementation of Share 35. Liver Transpl 2016;22:171-7. [PMID: 26437266 DOI: 10.1002/lt.24348] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
62 Tsuang WM, Lin S, Valapour M, Udeh BL, Budev M, Schold JD. The Association Between Lung Recipient Travel Distance and Posttransplant Survival. Prog Transpl 2018;28:231-5. [DOI: 10.1177/1526924818781570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ge J, Roberts JP, Lai JC. Race/ethnicity is associated with ABO-nonidentical liver transplantation in the United States. Clin Transplant 2017;31. [PMID: 28517242 DOI: 10.1111/ctr.13011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 Ioannou GN. Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma: Ioannou. Liver Transpl 2017;23:652-62. [DOI: 10.1002/lt.24690] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
65 Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Hepatol Int 2016;10:838-46. [DOI: 10.1007/s12072-016-9735-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
66 O'leary JG, Orloff SL, Levitsky J, Martin P, Foley DP. Keeping high model for end-stage liver disease score liver transplantation candidates alive: KEEPING LT CANDIDATES ALIVE. Liver Transpl 2015;21:1428-37. [DOI: 10.1002/lt.24329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
67 Sobotka LA, Hinton A, Conteh LF. Disparities in the treatment of hepatocellular carcinoma based on geographical region are decreasing. J Gastroenterol Hepatol 2019;34:575-9. [PMID: 30345600 DOI: 10.1111/jgh.14515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Beal EW, Tumin D, Sobotka L, Tobias JD, Hayes D Jr, Pawlik TM, Washburn K, Mumtaz K, Conteh L, Black SM. Patients From Appalachia Have Reduced Access to Liver Transplantation After Wait-Listing. Prog Transplant 2018;28:305-13. [PMID: 30205758 DOI: 10.1177/1526924818800037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Steggerda JA, Kim IK, Todo T, Malinoski D, Klein AS, Bloom MB. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era. J Am Coll Surg 2019;228:437-450.e8. [PMID: 30594593 DOI: 10.1016/j.jamcollsurg.2018.12.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
70 Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS; Advisory Committee on Improving Liver Allocation. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study. Sci Rep 2019;9:7495. [PMID: 31097768 DOI: 10.1038/s41598-019-43965-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
71 Goldberg DS, French B, Lewis JD, Scott FI, Mamtani R, Gilroy R, Halpern SD, Abt PL. Liver transplant center variability in accepting organ offers and its impact on patient survival. J Hepatol 2016;64:843-51. [PMID: 26626495 DOI: 10.1016/j.jhep.2015.11.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
72 Mooney JJ, Bhattacharya J, Dhillon GS. Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes. J Heart Lung Transplant 2019;38:136-44. [PMID: 30344025 DOI: 10.1016/j.healun.2018.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
73 Murken DR, Peng AW, Aufhauser DD Jr, Abt PL, Goldberg DS, Levine MH. Same policy, different impact: Center-level effects of share 35 liver allocation. Liver Transpl 2017;23:741-50. [PMID: 28407441 DOI: 10.1002/lt.24769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
74 Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol 2016; 22(10): 2922-2930 [PMID: 26973389 DOI: 10.3748/wjg.v22.i10.2922] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
75 Jackson KR, Cameron A. Liver Transplantation: Candidate Selection and Organ Allocation in the United States. Int Anesthesiol Clin 2017;55:5-17. [PMID: 28288029 DOI: 10.1097/AIA.0000000000000142] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Berumen J, Misel M, Vodkin I, Halldorson JB, Mekeel KL, Hemming A. The effects of Share 35 on the cost of liver transplantation. Clin Transplant 2017;31:e12937. [DOI: 10.1111/ctr.12937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]